Biochemical properties of attachment region binding protein ARBP  by von Kries, Jens P. et al.
FEBS Letters 342 (1994) 185-188 
mm 
LETTERS 
_ I 
ELSEVIER 
FEBS 13861 
Biochemical properties of attachment region binding protein ARBP 
Jens P. von Kries, Olaf Rosorius **, Hartmut Buhrmester, Wolf H. Strgtling* 
Institut fCr Physiologische Chemie. Universitiits-Krankenhaus Eppendorf; Martinistr 52, D-20246 Hamburg, Germany 
Received 27 January 1994 
ARBP (attachment region binding protein) is an abundant nuclear protein that specifically binds to matrix/scaffold attachment regions (MARs/ 
SARs). Here we show by gel tiltration and gradient sedimentation that ARBP has an elongated shape. The sedimentation coefficient was determined 
as only 2.1 S. Furthermore, limited proteolysis of ARBP in situ (in isolated nuclei) with several proteases generated limiting resistant peptides from 
14.5 to 18 kDa, that retained the ability to bind MARS specifically. This indicates that these peptides encompass the DNA binding domain of ARBP. 
Key word: Chromatin organization; ARBP; DNA binding domain; Sedimentation coefficient; Stokes radius 
1. Introduction 
Interphase chromatin is partitioned into topologically 
sequestered loop-domains [l]. There is evidence that 
these domains correspond to units of packaging as well 
as to units of gene regulation. It is thought that chroma- 
tin loops are generated by attachment of specific se- 
quences (MARs/SARS) to the nuclear matrix/chromoso- 
ma1 scaffold [2]. MARs/SARs have been characterized 
as AT-rich sequences, at least several hundred base pairs 
in length, that localize in some well studied cases to 
domain boundaries [3-51 (for reviews see [6,7]). In an 
attempt to analyse the attachment of MARS to nuclear 
matrix, we used a Southwestern blotting assay to identify 
proteins that specifically bind to MARS [8]. ARBP (at- 
tachment region binding protein) is one of the identified 
proteins. It is phylogenetically conserved, from Droso- 
phila to human, and recognizes several sites within the 
5’-MAR of the chicken lysozyme gene. Other laborato- 
ries have reported on the selective binding of additional 
known as well as newly discovered proteins to MARS: 
DNA topoisomerase II, lamin B,, histone Hl, SAT-Bl, 
and SAF-A [9-131. 
generated 14.5-18 kDa peptides that retained the ability 
to specifically recognize MARS. Furthermore, the be- 
haviour of ARBP in gel titration and glycerol gradients 
implies that the protein has an elongated shape. 
2. Materials and methods 
2.1. Materials 
Preparation of nuclear extracts from hen oviducts and purification 
of ARBP was performed as described previously [8]. 
2.2. Gel3ltration and glycerol gradient centrifugation 
Gel filtration was performed by chromatography on a Superose 6 
HR lo/30 column (Pharmacia) at 20°C in 0.05% Triton X-100,20 mM 
Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 
10% glycerol. Nuclear extract was applied to the column together with 
molecular weight standard proteins (Pharmacia): porcine thyroglobulin 
(669 kDa, 85 A), horse s leen ferritin (440 kDa, 61 A), bovine liver 
catalase (232 kDa, 52.5 K ), and bovine heart lactate dehydrogenase 
(140 kDa, 36 A) (values given by the manufacturer). The marker con- 
tents were analysed on SDS-polyacrylamide gels that were stained with 
Coomassie brilliant blue. The elution profile of ARBP was determined 
by a Southwestern blotting assay using the MAR fragment H 1 -HaeII 
as a probe [8]. 
In many DNA binding proteins, the ability for specific 
DNA binding resides in a protein domain, that can fold 
and act independently of the remaining molecule. In a 
search, whether ARBP also contains such a domain, we 
performed limited proteolysis of ARBP in situ, i.e. in 
purified nuclei. We demonstrate that various proteases 
To determine the sedimentation coefficient, purified ARBP was lay- 
ered together with marker proteins (Boehringer: horse cytochrome c, 
bovine chymotrypsinogen A, ovalbumin, bovine serum albumin) on top 
of a linear l&30% glycerol gradient in 20 mM Tris-HCl, pH 7.5, 
230 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol [14]. The gradient 
was centrifuged in a Beckman SW60 rotor at 56,000 rpm for 20 h at 
4°C. Fractions (200~1) were collected from the bottom of the tube, and 
the sedimentation profile of ARBP and marker proteins was deter- 
mined by Southwestern blotting assay and polyacrylamide gel electro- 
phoresis, respectively. 
*Corresponding author.Fax: (49) (40) 4717 4862. 
Two-dimensional polyacrylamide gel electrophoresis was performed 
using the O’Farrell minigel system [15,16] with p1 markers from Bio- 
Rad (hen egg white conalbumin, 6.66.6; bovine muscle actin, 5.5; 
bovine carbonic anhydrase, 5.96.0). 
2.3. Limited proteolysis 
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(1.5 mg DNA/ml) in 20 mM Tris-HCI, pH 7.5, 50 mM NaCl, 3 mM 
M&l, were incubated for IO min at 25°C in 100 ul aliauots with either 
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one of the following endoproteinases: bovine pancreatic elastase 
(Sigma), elastase from human leucocytes (Sigma), L-I-tosylamide-2- 
phenylethyl chloromethyl ketone-treated bovine pancreatic trypsin 
(Sigma), endoproteinase lys-C (Boehringer), and endoproteinase arg-C 
(Boehringer). Following digestion, reactions were stopped by the addi- 
tion of 20 ~1 of buffer E (1.6 M NaCl, 20 mM Tris-HCI, pH 7.5, 3 mM 
MgQ, 0.5% Z-mercapt~~~ol, 7.5 mM phenylmethyls~fonyl fluo- 
ride, 0.1 mg/ml Aprotinin (Sigma)). Samples were then extracted by 
vigorous shaking at 4°C for 45 min. After clarification in an Eppendorf 
centrifuge, 40 ~1 of the supernatants were mixed with IO pl of 5-fold 
sample buffer (62.5 mM Tris-HCI, pH 7.5,2% sodium dodecyl sulfate, 
10% glycerol, 140 mM 2-mercaptoethanol, 0.12% Bromophenol blue). 
Identification of ARBP and MAR binding fragments therefrom utilized 
a Southw~tem blotting assay [S] with el~trophoretic separation on 
8.5% (Fig. 3, panel G) or 13% (remaining panels) polyacrylamide gels. 
3. Results and discussion 
3.1. ARBP has an elongated shape 
Gel filtration and glycerol gradient sedimentation 
were used to examine the biochemical properties of 
ARBP. On Superose-6 chromatography in 300 mM 
NaCl with standard globular proteins, ARBP eluted as 
a symme&ical profile with an elution volume, which cor- 
responds to that of a globular protein with a mass of 
about 420 kDa (Fig. 1). However, in glycerol gradients 
with internal marker proteins purified ARBP sedimented 
rather slowly, at a position between those of cytochrome 
c (12.3 kDa) and chymotrypsinogen A (25 kDa). From 
four independent experiments, a sedimentation coeffi- 
cient of only 2.13 S (S.D. ? 0.086) was determined (Fig. 
2). Thus the sedimentation rate was much lower, but on 
the other hand the apparent mass on gel filtration was 
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Fig. 1. Gel filtration of ARBP. Nuclear extract was chromatographed 
on a Superose 6 column and eluted fractions were analysed for the 
content of ARBP using a Southwestern blotting assay. The elution 
positions of protein standards are indicated: thyroglobulin (Ty), ferritin 
(Fe), catalase (Ca), and lactate dehydrogenase (LDH). 
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Fig. 2. Sedimentation coefficient of ARBP. Puritied ARBP was sedi- 
mented in a glycerol gradient ogether with protein molecular weight 
standards (BSA, bovine serum albumin; Ov., ovalbumin; Chy., chymot- 
rypsinogen A; Cyt., cytochrome c with the S values [17] shown in 
brackets). Fractions were collected and analysed for the contents of 
marker proteins by SDS-PAGE (upper panel) and for that of ARBP 
by Southwestern blotting assay (lower panel). Lane M contains purified 
ARBP. 
much higher than expected for a globular m90 kDa pro- 
tein. Our results therefore indicate that ARBP has an 
elongated shape. There are several precedents for elon- 
gated nucleic acid-binding proteins, for example the 
mammalian poly(A)-binding protein II [18] and the yeast 
RNA polymerase II initiation factor a [19]. By compari- 
son with the marker proteins, we calculated for ARBP 
an apparent Stokes radius of about 6.0 nm. For several 
rod-shaped proteins, however, a discrepancy between the 
apparent Stokes radius determined by gel filtration and 
the Stokes radius derived by sedimentation measure- 
ments has been reported 120-221. Thus, the value of 
6.0 nm determined for ARBP is likely to be an underesti- 
mate. 
Furthermore, ARBP appears to be structurally very 
stable: not only is it stable to heat denaturation at 90°C 
but it can be isolated with its native DNA-binding prop- 
erties from trichloroa~tic acid precipitates (data not 
shown). The isoelectric point of ARBP was determined 
by two-dimensional gel electrophoresis as approximately 
6.1 (data not shown). 
The domain organization of ARBP was analysed by 
limited proteolysis of oviduct nuclei with either one of 
several endoproteases followed by extraction with 320 
mM NaCl. ARBP and proteolytic fragments therefrom, 
that retain the ability to specifically interact with MARS, 
were then identified by Southwestern biotting assay 
using the MAR probe Hl-HaeII [8]. Upon incubation of 
isolated nuclei with increasing concentrations of pancre- 
atic elastase, ARBP initially cleaved into two fragments 
with MAR binding activity, a fragment with an apparent 
size of approximately 81 kDa and a peptide with appar- 
ently 17 kDa (Fig. 3, panels A, B and C). At high concen- 
trations of elastase the 17 kDa peptide was processed 
into a 15 kDa species. The results from two experiments 
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Fig. 3. Limited proteolysis of ARBP in situ. Suspensions of oviduct nuclei were treated with 0 (lanes i), lx (lanes 2), 5x (lanes 3), 10x (lanes 4) or 
50x (lanes 5) units of pancreatic elastase (panels A, B and C), trypsin (panels E and F) or lys-C (panel G), or with 0 (lanes l), lx (lanes 2), 2x (lanes 
3), 10x (lanes 4) or 20x (lanes 5) units of elastase from human leucocytes (L. Elast.) (panel D) or arg-C (panel H), where x equals 8.9 x lO-4 for 
pancreatic elastase, 6 x 10W3 for elastase from leucocytes, 1.3 x lOA for trypsin, 2 x IO-’ for lys-C, and 1 x IO-’ for arg-C. Reactions were terminated, 
and ARBP and proteolytic fragments therefrom retaining MAR binding activity were extracted and identified by electrophoretic separation and 
incubation of the blotted proteins with the MAR probe HI-HaeII. For digestion with pancreatic elastase and trypsin two experiments are shown 
(exp. 1 and exp. 2). Panel C is a stronger exposure relative to panel B. M, marker proteins (molecular masses in kDa). The arrowheads mark the 
bands corresponding to uncleaved ARBP, and proteolytic fragments retaining MAR binding activity are indicated with their approximate molecular 
mass (in kDa). 
are shown: the 81 kDa inte~ediate is best resolved in 
panel A, lane 3, (exp.1) and panel B, lanes 2 and 3, (exp. 
2), while the 17 kDa and 15 kDa peptides are clearly 
separated in panel C, lanes 3-5, (exp. 2). Occasionally we 
observed small amounts of the 17 kDa peptide already 
in the non-digested sample (see panel C, lane l), proba- 
bly arising from slight endogenous proteolysis. Peptides 
with 17 kDa and 15 kDa retaining MAR binding activity 
were also generated by digestion with elastase from 
human leucocytes (panel D), demonstrat~g that these 
peptides are not products from cont~nating trypsin 
activity in the pancreatic elastase preparation. Digestion 
with trypsin also produced two MAR binding peptides 
with apparent sizes of approximately 17 kDa and 14.5 
kDa (panels E and F). Again the results from two exper- 
iments are shown: in the first one, the two resistant pep- 
tides are clearly resolved bane1 E, lanes 2-5). Incubation 
with the lysine-specific endoproteinase lys-C gave rise to 
a fragment with the apparent size of ~81 kDa (panel G), 
while the ar~nine-specific endoprotein~e arg-C gener- 
ated a peptide with = 15 kDa in size (panel H). Proteinase 
K, finally, produced an approximately 18 kDa peptide 
with MAR binding activity (data not shown). 
These results show that digestion of ARBP with en- 
doproteinases with different enzymatic specificities gen- 
erated limiting resistant peptides with apparent sizes 
from 14.5 to 18 kDa, that retained the ability to recog- 
nize the MAR fragment Hl-HaeII of the chicken ly- 
sozyme gene. Most likely these peptides are derived from 
the same region of ARBP and encompass the DNA bind- 
ing domain of the protein. Interestingly, we observed 
that ARBP was completely cleaved into 15-l 7 kDa pep- 
tides by trypsin, when there was yet no sign of proteolysis 
of the bulk of the nuclear proteins as examined on 
stained gels (data not shown). This suggests that ARBP 
is located at proteolytically exposed sites in chromatin. 
This agrees with the relative ease with which the protein 
can be extracted from nuclei (1~3~ mM NaCl) IS]. 
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